AIDS Treatment Activists Coalition

Agouron Pharmaceuticals
A Pfizer Company

ATAC DDC Liaisons: Ken Fornataro, Tom Gegeny, Cathy Olufs


COMPANY INFORMATION


MEETING AND CALL NOTES


CONTACT INFORMATION

Todd Mills
National Account Manager, HIV Relations
Pfizer Global Pharmaceuticals
10777 Science Center Drive
San Diego, CA 92121-1111 Phone: (858) 622-7674
Fax: (858) 526-4551
Email: [email protected]


PRODUCT INFORMATION

NOTE: Pfizer manufactures several drugs often used by people with HIV, including the following (links to individual product web sites):
Diflucan® (fluconazole)
Lipitor® (atorvastatin calcium)
Viagra® (sildenafil citrate)
Viracept® (nelfinavir mesylate)
Vfend® (voriconazole)
Zithromax® (azithromycin)
Zoloft® (sertraline HCL)

1. FDA-Approved Products:

Non-nucleoside reverse transcriptase inhibitor: delavirdine (Rescriptor®)
Protease inhibitor: nelfinavir (Viracept®)


2. Products in Clinical Trials:

Non-nucleoside reverse transcriptase inhibitor: Capravirine (Phase II)
CCR5 Inhibitor: UK-427,857 (Phase I)


Web pages:


KEY PERSONNEL

NOTE: Research and development activities are conducted by Pfizer Global Research and Development, with facilities in La Jolla, CA; and Sandwich, UK. Post-approval activities (marketing and community relations) are conducted by Agouron Pharmaceuticals, with offices in La Jolla, CA.

Pfizer Global Research Group
Peter Hawley, MD Director, Anti-Infectives (La Jolla)
Chris Hitchcock, PhD Senior Director, Exploratory Development (Sandwich)
Anne Jenkins Lead Project Manager, Global Project Management(Sandwich)

Agouron Pharmaceuticals
Elaine Daniels, MD, PhD Senior Director, Team Leader, Medical Affairs
Ann Kolokathis, MD Vice President, Medical Affairs
Bob Mischler Director, New Product Development
Richard Ogden, PhD Senior Director, Scientific Development
Carolyn Petersen, MD Medical Research Director
John Poyhonen Vice President, Marketing
Ron Roberts Senior Director, Government Affairs


Go to Main Page

email E-mail the Coalition

ATAC is a national coalition of people living with HIV/AIDS and advocates working together to end the AIDS epidemic by improving HIV research and treatment access.